JJDC Strategy Emphasizes the J & the J
Executive Summary
Under the leadership of new president David Holveck, Johnson & Johnson Development Corp. is aligning its strategy more closely with the needs and wants of J&J's many companies.
You may also be interested in...
Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition
Responding to a convergence of a changing market and shifts in technology, pharmaceutical companies are exploring ways to enhance the value of their products and find new opportunities beyond their core molecule-driven businesses.
Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition
Responding to a convergence of a changing market and shifts in technology, pharmaceutical companies are exploring ways to enhance the value of their products and find new opportunities beyond their core molecule-driven businesses.
Corporate Venture Strikes Again: Biocartis Lands €30 million--And A Partnership
The two deals help pave a path toward commercialization for the privately-held Swiss molecular diagnostics player.